Integrated BioPharma, Inc. (INBP)
0.167
-0.01
(-7.22%)
USD |
OTCM |
Aug 24, 16:00
Integrated BioPharma Net Income (Quarterly) : -0.837M for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.837M |
| December 31, 2025 | -0.762M |
| September 30, 2025 | 0.123M |
| June 30, 2025 | -0.178M |
| March 31, 2025 | 0.611M |
| December 31, 2024 | 0.116M |
| September 30, 2024 | 0.259M |
| June 30, 2024 | 0.268M |
| March 31, 2024 | 0.285M |
| December 31, 2023 | -0.382M |
| September 30, 2023 | -0.059M |
| June 30, 2023 | 0.04M |
| March 31, 2023 | 0.016M |
| December 31, 2022 | -0.055M |
| September 30, 2022 | -0.035M |
| June 30, 2022 | 1.494M |
| March 31, 2022 | 0.797M |
| December 31, 2021 | 1.031M |
| September 30, 2021 | 0.516M |
| June 30, 2021 | 4.507M |
| March 31, 2021 | 1.241M |
| December 31, 2020 | 1.224M |
| September 30, 2020 | 1.041M |
| June 30, 2020 | 1.901M |
| March 31, 2020 | 0.936M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.959M |
| September 30, 2019 | 0.312M |
| June 30, 2019 | 0.36M |
| March 31, 2019 | 0.923M |
| December 31, 2018 | 0.246M |
| September 30, 2018 | 0.159M |
| June 30, 2018 | 0.818M |
| March 31, 2018 | 0.388M |
| December 31, 2017 | -0.348M |
| September 30, 2017 | -0.179M |
| June 30, 2017 | 1.536M |
| March 31, 2017 | 0.238M |
| December 31, 2016 | -0.077M |
| September 30, 2016 | 0.649M |
| June 30, 2016 | 0.747M |
| March 31, 2016 | 0.033M |
| December 31, 2015 | -0.063M |
| September 30, 2015 | 0.241M |
| June 30, 2015 | -0.11M |
| March 31, 2015 | -0.106M |
| December 31, 2014 | 0.547M |
| September 30, 2014 | 0.403M |
| June 30, 2014 | -0.114M |
| March 31, 2014 | -0.45M |
| December 31, 2013 | 0.397M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Medifast, Inc. | -3.10M |
| BioForce Nanosciences Holdings, Inc. | 0.2387M |
| Skinvisible, Inc. | -0.2555M |
| Nevis Brands, Inc. | -0.1707M |
| Skinhealth Systems, Inc. | -2.669M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 10.11M |
| Total Expenses (Quarterly) | 10.94M |
| EPS Diluted (Quarterly) | -0.027 |
| Enterprise Value | 2.707M |
| Gross Profit Margin (Quarterly) | -2.73% |
| Profit Margin (Quarterly) | -8.28% |
| Earnings Yield | -31.98% |
| Normalized Earnings Yield | -31.98 |